Tiia Kangas-Kontio is the Senior Genetics Director in the Clinical Interpretation (CI) team. She collaborates with other CI directors, associate laboratory directors, and managers, and leads the maintenance, development, and updates in interpretation processes, reporting policies, and tools. She provides support, guidance, and feedback to relevant topics across the organization and works with her team to ensure competency as well as appropriate tools to perform their work with high quality. She received her MSc degree from University of Turku in 2004 and her PhD in 2011, where she focused on the genetics of cardiovascular disease at the University of Oulu. She worked as a visiting researcher in the Wellcome Sanger Institute, Cambridge, UK, during her post-doctoral studies. She joined Blueprint Genetics in 2015 and has worked as a geneticist and team manager before her current position.